Nebraska Pulmonary Specialties, LLC

Lincoln, Nebraska 68510

0 studies enrolling now · 4 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension

Studies at this site

• A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis — Stopped early
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program — Completed
• Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies — Completed